Cargando…

Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials

BACKGROUND: Dzherelo (Immunoxel) is one of the few approved immunomodulators that has been shown to produce positive treatment outcomes in patients with tuberculosis (TB). The aim of this review was to assess the effectiveness of Immunoxel used as adjunct therapy with conventional anti-TB therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitenge, Marcel, Phiri, Bessie, Pheeha, Sara M., Ogunrombi, Modupe, Nyasulu, Peter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157410/ https://www.ncbi.nlm.nih.gov/pubmed/34039420 http://dx.doi.org/10.1186/s13643-021-01698-2

Ejemplares similares

Effect of Immunomodulating Adjuvant Dzherelo (Immunoxel) in HIV Infected Patients Receiving Standard Antiretroviral Therapy
por: Nikolaeva, Lyudmila G, et al.
Publicado: (2009)

Factors associated with high HIV-related stigma among commuter populations in Johannesburg, South Africa
por: Nyasulu, Peter S., et al.
Publicado: (2021)

An investigation of maternal anaemia among HIV infected pregnant women on antiretroviral treatment in Johannesburg, South Africa
por: Methazia, Jewelle, et al.
Publicado: (2020)

Evaluating determinants of treatment outcomes among tuberculosis patients in the mining district of Butha Buthe, Lesotho
por: Ngah, Veranyuy D., et al.
Publicado: (2022)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Identifying Gut Microbiota Conditions Associated with Disease in the African Continent: A Scoping Review Protocol
por: Pheeha, Sara M., et al.
Publicado: (2022)

Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis
por: Han, Yi-Ran, et al.
Publicado: (2022)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment
por: Peresi, Eliana, et al.
Publicado: (2013)

Effects of antiretroviral therapy in HIV-positive adults on new HIV infections among young women: a systematic review protocol
por: Chibawara, Trust, et al.
Publicado: (2019)

Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?
por: Maphalle, Lehlogonolo N. F., et al.
Publicado: (2022)

Prevalence and trends of advanced HIV disease among antiretroviral therapy-naïve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis
por: Kitenge, Marcel K., et al.
Publicado: (2023)

The Effect of an Antituberculosis Serum on the Development of Experimental Tuberculosis of the Skin
por: Thomas, Robert M., et al.
Publicado: (1940)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients
por: Nikolaeva, Lyudmila G, et al.
Publicado: (2009)

A Scoping Review Evaluating the Current State of Gut Microbiota Research in Africa
por: Pheeha, Sara M., et al.
Publicado: (2023)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
por: Kalo, Deepika, et al.
Publicado: (2015)

Adjunctive corticosteroid therapy in patients with pulmonary tuberculosis
por: Lemos, Carolina Xavier, et al.
Publicado: (2022)

Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis
por: Lailulo, Yishak, et al.
Publicado: (2020)

Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda
por: Nsubuga, Peter, et al.
Publicado: (2002)

First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B
por: Hasnain, Md Golam, et al.
Publicado: (2014)

Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report
por: Soeharto, Diajeng Ayesha, et al.
Publicado: (2019)

Microencapsulated Isoniazid-Loaded Metal–Organic Frameworks for Pulmonary Administration of Antituberculosis Drugs
por: Fernández-Paz, Cristina, et al.
Publicado: (2021)

The dilemma in a case of immune thrombocytopenia in a patient with human immunodeficiency virus on antituberculosis treatment for miliary pulmonary tuberculosis
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2019)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Mycobacterium tuberculosis Specific CD8(+) T Cells Rapidly Decline with Antituberculosis Treatment
por: Nyendak, Melissa R., et al.
Publicado: (2013)

The Expression of lncRNA NEAT1 in Human Tuberculosis and Its Antituberculosis Effect
por: Huang, Shuying, et al.
Publicado: (2018)

Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
por: Aspatwar, Ashok, et al.
Publicado: (2019)

Unintended pregnancies among HIV-positive women in sub-Saharan Africa: a scoping review protocol
por: Oguntade, Racheal Tomilola, et al.
Publicado: (2023)

Correction: Unintended pregnancies among HIV‑positive women in sub‑Saharan Africa: a scoping review protocol
por: Oguntade, Racheal Tomilola, et al.
Publicado: (2023)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus‐associated tuberculosis
por: Schutz, Charlotte, et al.
Publicado: (2020)

Successful diagnosis and management of tuberculosis verrucosa cutis using antituberculosis therapy trial approach
por: Pebriany, Dina, et al.
Publicado: (2020)

Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis
por: Sheng, Lina, et al.
Publicado: (2022)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

Plasma host protein signatures correlating with Mycobacterium tuberculosis activity prior to and during antituberculosis treatment
por: Ndiaye, Mame Diarra Bousso, et al.
Publicado: (2022)

Effects of antituberculosis treatment on pregnancy outcomes in infertile women with genital tuberculosis: a systematic review
por: Flores-Lovon, Kevin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bd83l3kg7i1nagoprvsefnhshv